mimiX Biotherapeutics

Can Sound Waves Unlock New Paths to Healing? At mimiX, we’re developing a technology called Sound-Induced Morphogenesis, which uses acoustic waves to stimulate tissue repair in unprecedented ways! Recently featured in SATW’s Technology Outlook, our innovative approach has the potential to open up non-invasive healing options that work with the body’s natural processes. Check out the article to see how Mimix is reimagining the role of sound in healthcare: https://lnkd.in/eB78Kttw Swiss Academy of Engineering Sciences SATW

Redefining Tissue Engineering with Sound – A New Revolution Begins Ernst Chladni's groundbreaking work on visualizing sound through patterns on metal plates is a true cornerstone of acoustics, inspiring fields as diverse as mathematics, visual arts, and modern technologies. By demonstrating sound vibrations in real-time, his techniques—using dust on plates to reveal intricate patterns—opened new perspectives on wave behavior. Today, his legacy persists, impacting 85% of acousticians worldwide, with applications reaching far beyond traditional acoustics. From Visualization to Cellular Transformation: Mimix Biotherapeutics and Sound Induced Morphogenesis Our collaboration with Mimix Biotherapeutics and their innovative Sound Induced Morphogenesis technology builds on Chladni’s principles by using controlled sound waves to influence cell behavior in 3D cultures. Just as Chladni’s plates visualize acoustic patterns, Mimix's technology manipulates cells in real-time, offering unique advantages for creating organized, complex structures in our organoid research. This synergy between sound and cellular organization enables us to better mimic human tissue structures, accelerating breakthroughs in regenerative medicine and drug discovery. Here is the link to our video where you’ll see our organoids dancing ! https://lnkd.in/eDRCryC2 With Mimix, we’re pushing the boundaries of organoid development, working to create more lifelike models and to explore therapeutic applications. By merging Chladni-inspired concepts with cutting-edge biomedical applications, we are advancing towards personalized medicine solutions that could redefine patient-specific treatments. #Organoids #Chladni #SoundInducedMorphogenesis #InnovationInMedicine #BiomedicalResearch #Acoustics #3D #NAM #RegenerativeMedicine #LBTI #SFRBiosciences #MimixBiotherapeutics #HCL #CRCL #ENS #CNRS #INSERM #INRAE #UCBL #LYON #3DBIO

What if sound could build the future of medicine? At mimiX, we're excited to highlight a groundbreaking technology that uses sound to assemble magnetically actuated soft robots—paving the way for a new era of precision in extracellular vesicle (EV) release! Imagine soft robots, shaped like fish or butterflies, that fold, bend, and expand under magnetic fields, delivering therapeutic EVs with unprecedented accuracy. This cutting-edge, contactless assembly method is faster, more biocompatible, and opens up limitless possibilities for drug delivery and cell therapy. This breakthrough could reshape how we approach personalized medicine. The future is here—and it’s built by sound. Stay tuned for more! Huge congrats to Wei Gao and the whole team! Tiziano Serra Riccardo Tognato Micaela Natta Elena Della Bella Alessandro Cianciosi AO Research Institute Davos (ARI) #biotech #softrobots #extracellularvesicles #innovation #futureofmedicine #healthtech https://lnkd.in/e7rHVTAt

Next week, mimiX will be attending the Symposium on Advanced Wound Care (SAWC) Fall Congress in Las Vegas – the premier event for wound care professionals and innovators! We’re excited to connect with the global community and share how Mimix is aiming to transform the future of wound healing. 📅 When: Oct 2-5 📍 Where: Las Vegas, NV Our team will be on-site, ready to discuss the latest advancements in wound care and explore new opportunities to improve patient outcomes. We look forward to engaging with fellow healthcare leaders, exchanging ideas, and pushing the boundaries of what's possible. Let’s meet in Las Vegas! #SAWC2024

We’re thrilled to see our technology being used in such groundbreaking research! Ariane Leonard, an MSc student, is pushing the boundaries of #BioArt by using our acoustic wave tools to replicate the intricate patterns found in human tissues and organs. This work has huge potential for organ-on-chip and tissue engineering applications, and we couldn’t be prouder to support this innovative journey.

Pythagoras once said, "There is geometry in the humming of the strings, there is music in the spacing of the spheres." He wasn't just talking about mathematics; he was pointing to something much deeper—the Harmonic Series. The Harmonic Series is a sequence that reveals the fundamental frequencies at which objects resonate. It’s not just a mathematical curiosity; it's the very foundation of harmony in music and structure in nature. At MimiX, we're not just playing with sound—we’re orchestrating life. Our work with Sound-Induced Morphogenesis harnesses the same principles that Pythagoras hinted at centuries ago. We use sound waves to guide cells into forming complex structures, creating a new frontier in biotechnology. When you think about it, life itself is a symphony—an intricate composition where every note matters. And just like the Harmonic Series, where each frequency builds upon the previous, our technology builds life, one wave at a time. Curious to learn more about how we're making waves in biotech? Let's connect! P.S. What’s your favorite example of nature’s hidden harmonies? Share below 👇 (And if you found this as fascinating as we do, don’t forget to repost for your network!)

🌴 Welcome to the West Coast! The four Swiss biotech startups that visited us in Boston last week were in San Diego this week for #BIO2024. The BIO International Convention attracts thousands of biotech companies from around the world, from big pharma to the most innovative startups. At the #SwissBiotech Pavilion, Nagi Bioscience, mimiX Biotherapeutics, Cellestia Biotech, and Amphilix AG took the opportunity to meet and network with potential partners, manufacturers, investors, and other founders. Hear what one of our participants had to say about the experience: “We have been leveraging our presence at BIO 2024 to meet with investors, aiming to raise our seed financing round. The program offered by Swissnex and Innosuisse has helped us develop connections with potential pharma partners and enhance our visibility within the biotech community in the US.” - Guido Koch, Amphilix We look forward to following these four startups as they continue their journeys, and we hope to see them back in the US soon! A special thank you goes out to Switzerland Global Enterprise for hosting us at the Swiss Biotech Pavilion and to all of Team Switzerland for the fantastic collaboration! Swiss Biotech Association Innosuisse Swiss Business Hub USA

Discover the future of #biotechnology! Dive into the revolutionary world of #organoid research with Nicolas Aznar, Jerome Sohier and Lucas Lemarié in Lyon, France. Discover how Mimix Biotherapeutics' revolutionary SIM (Sound Induced Morphogenesis) technology is transforming the landscape of scientific exploration. Curious to discover the synergy between sound waves and tissue development? Don't miss this exciting journey into the orchestration of #biology. #organoids #lifescience #stemcells

This week, four Swiss #biotech startups joined us in Boston for a three-day program on their way to the BIO International Convention in San Diego next week. Meet the startups and find out more about their experience in Boston as part of the Innosuisse Internationalization Camps! 🚀 The startups are: Nagi Bioscience, whose SydLab System is a benchtop laboratory device allowing standardized drug and chemical testing on microorganisms within disposable microfluidic cartridges. mimiX Biotherapeutics which has developed FastSkin, a dermal substitute developed by mimiX using their Sound Induced Morphogenesis technology, offers a novel solution to help patients struggling to heal from complex wounds. Cellestia Biotech is a fully integrated R&D company specialized in innovative therapeutics with new modes of action to treat autoimmune diseases and multidrug resistant cancers. Amphilix AG is developing small molecular chimeras utilizing a unique linker platform that enables fine-tuning of molecular properties, raising the bar for standard-of-care treatment and addressing unmet medical needs. Here’s what they’ve been up to this week: ⚖️ In a session on incorporation with Laura Stoffel (Gunderson Dettmer) they discussed types of legal structures in the US and their implications. 👨💻 With Alexander Harrall (TriNet) they learned how to hire in the US and discover cultural differences in the recruitment process to attract the best talent. 📃 James Ravitz (McDermott Will & Emery) shared insights on the FDA’s regulatory approval process and got them ready for expansion. 🧪 With Alberto Nobili, the startups got the chance to tour Bayer Co.Lab, an incubator for early-stage healthcare startups. 👥 In a feedback session with investors Doug Zingale and Edward Melia the startups got invaluable advice on their pitches and practiced how to adjust them to the local audience. 🗃️ In a session on taxation with Gerhard Friedrich Schneiders (Rödl & Partner USA) they discussed differences between Switzerland and the US, and the tax implications of different legal entities. 📣 Finally, with Mehdi Aghdaee, MD, PhD (#QuantLifeSciences), they worked on their storytelling skills, practicing how to create a storyline and capture an audience - which will come in handy next week! We welcomed the startups to the US with our Biotech Garden Party, where they were able to meet and network with members of Boston’s biotech community, including representatives from Novartis, Sanofi, Pfizer, and many others who will be attending #BIO2024. Thanks to all who attended the event, and especially to Innosuisse, Greater Zurich Area, Greater Geneva Bern area (GGBa), and Switzerland Global Enterprise for their partnership. Thank you as well to all the experts who shared their time and knowledge with the startups throughout the week! 🙏🏼 Next stop, San Diego! 🌴 #SwissBiotech #SwissStartups

Our CEO Marc Thurner will be attending the BIO International Convention in San Diego, diving into groundbreaking discussions and exploring business & scientific collaborations to push the boundaries of #biotechnology. This is a fantastic opportunity to connect with innovative minds and industry leaders. Are you attending Bio International Convention too? We’d love to meet up! Let's discuss how we can collaborate to drive business & scientific advancements together.